Editorial
doi: 10.1056/NEJMe1409369.
Epub 2014 Aug 31.
The challenges with chronic angina
Affiliations
- PMID: 25176137
- DOI: 10.1056/NEJMe1409369
Item in Clipboard
Editorial
The challenges with chronic angina
N Engl J Med.
.
No abstract available
Comment on
-
Ivabradine in stable coronary artery disease without clinical heart failure.N Engl J Med. 2014 Sep 18;371(12):1091-9. doi: 10.1056/NEJMoa1406430. Epub 2014 Aug 31. N Engl J Med. 2014. PMID: 25176136 Clinical Trial.
Similar articles
-
Ivabradine in stable coronary artery disease.N Engl J Med. 2014 Dec 18;371(25):2435. doi: 10.1056/NEJMc1413158. N Engl J Med. 2014. PMID: 25517717 No abstract available.
-
Ivabradine in stable coronary artery disease.N Engl J Med. 2014 Dec 18;371(25):2435. doi: 10.1056/NEJMc1413158. N Engl J Med. 2014. PMID: 25517716 No abstract available.
-
Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.Curr Cardiol Rep. 2016 Feb;18(2):13. doi: 10.1007/s11886-015-0689-2. Curr Cardiol Rep. 2016. PMID: 26768739 Review.
-
Elevated heart rate proven to increase coronary events.Cardiovasc J Afr. 2008 Sep-Oct;19(5):276-8. Cardiovasc J Afr. 2008. PMID: 18997992 No abstract available.
-
Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.Ann N Y Acad Sci. 2011 Mar;1222:90-9. doi: 10.1111/j.1749-6632.2011.05960.x. Ann N Y Acad Sci. 2011. PMID: 21434947 Review.
Cited by
-
A pathophysiological compass to personalize antianginal drug treatment.Nat Rev Cardiol. 2021 Dec;18(12):838-852. doi: 10.1038/s41569-021-00573-w. Epub 2021 Jul 7. Nat Rev Cardiol. 2021. PMID: 34234310 Review.
-
Heart rate reduction in coronary artery disease and heart failure.Nat Rev Cardiol. 2016 Aug;13(8):493-501. doi: 10.1038/nrcardio.2016.84. Epub 2016 May 26. Nat Rev Cardiol. 2016. PMID: 27226153 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
